Org.nr 983 931 014 2023 → 2024 Year-over-year analysis

ADVANCED BIOPOLYMERS AS: årsregnskap 2024 vs 2023

Cash halved-plus

approved 2025-04-03; registry 2025-04-07; journal 2025 365686

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2024 with 2023 for ADVANCED BIOPOLYMERS AS. Revenue 0 NOK → 0 NOK (0.0%). Net result -394 NOK → -3 094 NOK. Equity 75.5k NOK → -3 018 NOK.

Pressures included: operating result weakened; net result weakened; equity eroded.

Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for ADVANCED BIOPOLYMERS AS.

Scorecard

Revenue
0 NOK 0 NOK
0.0%
Operating result
-1 194 NOK -3 094 NOK
-159.1%
Net result
-394 NOK -3 094 NOK
-685.3%
Equity
75.5k NOK -3 018 NOK
-104.0%
Cash
76.5k NOK 282 NOK
-99.6%
Total assets
76.5k NOK 282 NOK
-99.6%

What deteriorated

  • ↓

    Operating result weakened

    Operating result -1 194 NOK → -3 094 NOK. Calculated

  • ↓

    Net result weakened

    Net result -394 NOK → -3 094 NOK. Calculated

  • ↓

    Equity eroded

    Book equity 75.5k NOK → -3 018 NOK (equity ratio 98.7% → -1070.2%). Calculated

  • ↓

    Cash fell

    Bank deposits 76.5k NOK → 282 NOK (-99.6% YoY). Calculated

Things to notice

  • ·

    Thin equity buffer

    Equity ratio is -1070.2% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation